In 2007, we were able to launch the first drug in Japan to improve melasma, a type of blemish, thanks to the combined strength of the pharmaceutical company, the power of the product, and the conviction and passion of the developer. Then, in 2014, seven years after its launch, after listening to customer feedback and accumulating research into blemish care, the Transino brand has evolved into a total care series for not only melasma but also blemishes. We want to support the beauty of busy people, so we will tell you the story behind the development of the Transino brand, which overcame many hurdles.
